[HTML][HTML] Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients
F Vincenti, CP Larsen, J Alberu, B Bresnahan… - American journal of …, 2012 - Elsevier
The clinical profile of belatacept in kidney transplant recipients was evaluated to determine if
earlier results in the BENEFIT study were sustained at 3 years. BENEFIT is a randomized 3 …
earlier results in the BENEFIT study were sustained at 3 years. BENEFIT is a randomized 3 …
Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients.
F Vincenti, CP Larsen, J Alberu… - American Journal of …, 2011 - europepmc.org
The clinical profile of belatacept in kidney transplant recipients was evaluated to determine if
earlier results in the BENEFIT study were sustained at 3 years. BENEFIT is a randomized 3 …
earlier results in the BENEFIT study were sustained at 3 years. BENEFIT is a randomized 3 …
Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients
F Vincenti, CP Larsen, J Alberu… - … : official journal of …, 2012 - pubmed.ncbi.nlm.nih.gov
The clinical profile of belatacept in kidney transplant recipients was evaluated to determine if
earlier results in the BENEFIT study were sustained at 3 years. BENEFIT is a randomized 3 …
earlier results in the BENEFIT study were sustained at 3 years. BENEFIT is a randomized 3 …
[HTML][HTML] Three-Year Outcomes from BENEFIT, a Randomized, Active-Controlled, Parallel-Group Study in Adult Kidney Transplant Recipients
F Vincenti, CP Larsen, J Alberu… - American Journal of …, 2012 - amjtransplant.org
The clinical profile of belatacept in kidney transplant recipients was evaluated to determine if
earlier results in the BENEFIT study were sustained at 3 years. BENEFIT is a randomized 3 …
earlier results in the BENEFIT study were sustained at 3 years. BENEFIT is a randomized 3 …
Three‐Year Outcomes from BENEFIT, a Randomized, Active‐Controlled, Parallel‐Group Study in Adult Kidney Transplant Recipients
F Vincenti, CP Larsen, J Alberu… - American Journal of …, 2012 - Wiley Online Library
The clinical profile of belatacept in kidney transplant recipients was evaluated to determine if
earlier results in the BENEFIT study were sustained at 3 years. BENEFIT is a randomized 3 …
earlier results in the BENEFIT study were sustained at 3 years. BENEFIT is a randomized 3 …
Three‐Year Outcomes from BENEFIT, a Randomized, Active‐Controlled, Parallel‐Group Study in Adult Kidney Transplant Recipients
F Vincenti, CP Larsen, J Alberu, B Bresnahan… - American Journal of …, 2012 - infona.pl
The clinical profile of belatacept in kidney transplant recipients was evaluated to determine if
earlier results in the BENEFIT study were sustained at 3 years. BENEFIT is a randomized 3 …
earlier results in the BENEFIT study were sustained at 3 years. BENEFIT is a randomized 3 …
[引用][C] Three-Year Outcomes from BENEFIT, a Randomized, Active-Controlled, Parallel-Group Study in Adult Kidney Transplant Recipients
F Vincenti, CP Larsen, J Alberu, B Bresnahan… - American Journal of …, 2012 - cir.nii.ac.jp
Three-Year Outcomes from BENEFIT, a Randomized, Active-Controlled, Parallel-Group Study in
Adult Kidney Transplant Recipients | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
Adult Kidney Transplant Recipients | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
[引用][C] Three-Year Outcomes from BENEFIT, a Randomized, Active-Controlled, Parallel-Group Study in Adult Kidney Transplant Recipients
F VINCENTI, CP LARSEN… - American journal of …, 2012 - pascal-francis.inist.fr
Author VINCENTI, F 1; LARSEN, C. P 2; REYES-ACEVEDO, R 11; RICE, K 12; ROSTAING,
L 13; STEINBERG, S 14; XING, J 15; AGARWAL, M 15; HARLER, M. B 15; CHARPENTIER …
L 13; STEINBERG, S 14; XING, J 15; AGARWAL, M 15; HARLER, M. B 15; CHARPENTIER …
[PDF][PDF] Three-Year Outcomes from BENEFIT, a Randomized, Active-Controlled, Parallel-Group Study in Adult Kidney Transplant Recipients
F Vincentia, CP Larsenb, J Alberuc… - American Journal of …, 2011 - Citeseer
The clinical profile of belatacept in kidney transplant recipients was evaluated to determine if
earlier results in the BENEFIT study were sustained at 3 years. BENEFIT is a randomized 3 …
earlier results in the BENEFIT study were sustained at 3 years. BENEFIT is a randomized 3 …